Literature DB >> 3020089

Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats.

A Ohnishi, R A Branch, K Jackson, R Hamilton, I Biaggioni, G Deray, E K Jackson.   

Abstract

The purpose of this study was to determine whether or not caffeine would exacerbate renovascular hypertension. Therefore, we examined the effects of chronic caffeine administration on arterial blood pressure in rats subjected to either unilateral renal artery clipping (2K-1C rats) or sham-operation. Animals in each group were randomly assigned to receive either 0.1% caffeine in their drinking water or normal drinking water, and systolic blood pressure was monitored for 6 wk. Caffeine markedly exacerbated the severity of hypertension in 2K-1C rats and caused histological changes consistent with malignant hypertension. 6 wk after surgery, systolic blood pressure, plasma renin activity, and creatinine clearance in control 2K-1C rats were 169 +/- 5 mmHg (mean +/- SEM), 4.4 +/- 0.5 ng AI X ml-1 X h-1, and 2.9 +/- 0.2 ml/min, respectively; as compared with 219 +/- 4 mmHg, 31.8 +/- 7.8 ng AI X ml-1 X h-1, and 1.4 +/- 0.3 ml/min, respectively, in 2K-1C rats receiving caffeine (all values were significantly different compared with control 2K-1C). Chronic caffeine administration did not alter systolic blood pressure, plasma renin activity, or creatinine clearance in sham-operated rats or spontaneously hypertensive rats. Chronic treatment with enalapril (a converting enzyme inhibitor) prevented the development of hypertension in control 2K-1C rats and caffeine-treated 2K-1C rats; however, withdrawal of enalapril precipitated a rapid rise in systolic blood pressure in caffeine-treated 2K-1C rats, but not in control 2K-1C rats. These experiments indicate that caffeine specifically exacerbates experimental renovascular hypertension and might worsen the hypertensive process in patients with renovascular hypertension.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020089      PMCID: PMC423756          DOI: 10.1172/JCI112659

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Hemodynamic effects of adenosine in conscious hypertensive and normotensive rats.

Authors:  A Ohnishi; I Biaggioni; G Deray; R A Branch; E K Jackson
Journal:  Hypertension       Date:  1986-05       Impact factor: 10.190

2.  Relationship between arterial and venous adenosine levels and vasodilatation during ATP- and adenosine-infusion in dogs.

Authors:  A Sollevi; M Lagerkranser; M Andreen; L Irestedt
Journal:  Acta Physiol Scand       Date:  1984-02

Review 3.  Modulation of neurotransmission by purine nucleotides and nucleosides.

Authors:  B B Fredholm; P Hedqvist
Journal:  Biochem Pharmacol       Date:  1980-06-15       Impact factor: 5.858

4.  Chronic caffeine consumption potentiates the hypotensive action of circulating adenosine.

Authors:  R W von Borstel; R J Wurtman; L A Conlay
Journal:  Life Sci       Date:  1983-03-07       Impact factor: 5.037

5.  Tolerance to the humoral and hemodynamic effects of caffeine in man.

Authors:  D Robertson; D Wade; R Workman; R L Woosley; J A Oates
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

6.  Tail-cuff blood pressure measurement without external preheating in awake rats.

Authors:  R D Buñag; J Butterfield
Journal:  Hypertension       Date:  1982 Nov-Dec       Impact factor: 10.190

7.  Improved high-performance liquid chromatographic method for the simultaneous determination of caffeine and its N-demethylated metabolites in plasma using solid-phase extraction.

Authors:  R Hartley; I J Smith; J R Cookman
Journal:  J Chromatogr       Date:  1985-07-12

8.  Caffeine and hypertension.

Authors:  D Robertson; A S Hollister; D Kincaid; R Workman; M R Goldberg; C S Tung; B Smith
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

9.  Renal handling and production of plasma and urinary adenosine.

Authors:  C I Thompson; H V Sparks; W S Spielman
Journal:  Am J Physiol       Date:  1985-04

10.  Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.

Authors:  U Schwabe; D Ukena; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

View more
  9 in total

1.  Methylxanthines augment the renin response to suprarenal-aortic constriction.

Authors:  G Deray; R A Branch; E K Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

2.  Adenosine inhibits renin release induced by suprarenal-aortic constriction and prostacyclin.

Authors:  G Deray; R A Branch; A Ohnishi; E K Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

3.  Caffeine enhances the slow-pressor response to angiotensin II in rats. Evidence for a caffeine-angiotensin II interaction with the sympathetic nervous system.

Authors:  A Ohnishi; P Li; R A Branch; B Holycross; E K Jackson
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

4.  Effect of Caffeine Chronically Consumed During Pregnancy on Adenosine A1 and A2A Receptors Signaling in Both Maternal and Fetal Heart from Wistar Rats.

Authors:  Inmaculada Iglesias; Jose Luis Albasanz; Mairena Martín
Journal:  J Caffeine Res       Date:  2014-12-01

Review 5.  Methylxanthines and the kidney.

Authors:  Hartmut Osswald; Jürgen Schnermann
Journal:  Handb Exp Pharmacol       Date:  2011

6.  Association between Tea Consumption and Hypertension Risk among Middle-Aged and Older Chinese Adults.

Authors:  Chengwu Feng; Yaying Cao; Yang Su; Hui Cai; Xiao-Ou Shu; Wei Zheng; Danxia Yu; Geng Zong
Journal:  J Nutr       Date:  2021-12-03       Impact factor: 4.687

Review 7.  Caffeine in Kidney Stone Disease: Risk or Benefit?

Authors:  Paleerath Peerapen; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

8.  Thyroid hormone stimulates 5'-ecto-nucleotidase of neonatal rat ventricular myocytes.

Authors:  Marcela Sorelli Carneiro-Ramos; Vanessa Beatriz da Silva; Marconi Barbosa Coutinho; Ana Maria Oliveira Battastini; João José Freitas Sarkis; Maria Luiza M Barreto-Chaves
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

9.  Caffeine's Vascular Mechanisms of Action.

Authors:  Darío Echeverri; Félix R Montes; Mariana Cabrera; Angélica Galán; Angélica Prieto
Journal:  Int J Vasc Med       Date:  2010-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.